A large percentage of people who seek treatment for substance or alcohol use disorder also have other mental health disorders on board, such as depression or anxiety. When this is the case, it is referred to as having a co-occurring disorder, and successful recovery hinges on treating both. What’s more, people’s depression or anxiety may play a part in people forming an addiction. In fact, new research suggests that people living with high levels of depression or anxiety, and experience chronic lower back pain, are significantly more prone to developing a problem with prescription opioids, Medical News Today reports. People with chronic lower back pain and high levels of depression or anxiety were 75 percent more likely to abuse opioids than people with low levels, and their back pain was less likely to improve. The researchers involved in the study examined 55 patients with chronic lower back, as well as major or minor levels of anxiety or depression, according to the article. Over the course of 6-months, the patients were given oral forms of morphine, oxycodone or a placebo. The patient's pain levels and the amount of drugs taken were recorded daily. There was 50 percent less improvement and 75 percent more opioid abuse among patients who had high levels of depression or anxiety, compared with patients with low levels. The findings suggest that doctors treating patients with lower back pain, who show symptoms of mental illness, should make sure that the mental illness is being treated rather than "refusing to prescribe opioids," according to lead researcher Prof. Ajay Wasan, at the University of Pittsburgh School of Medicine. This may reduce the likelihood of opioid abuse and reduce pain. “High levels of depression and anxiety are common in patients with chronic lower back pain,” Wasan said in a news release. “Learning that we are able to better predict treatment success or failure by identifying patients with these conditions is significant. This is particularly important for controlled substances such as opioids, where if not prescribed judiciously, patients are exposed to unnecessary risks and a real chance of harm, including addiction or serious side effects.” The study is published in Anesthesiology. ___________________________________________________________________________ If you or a loved one is struggling with opioid addiction and depression or anxiety, please contact Pace Recovery Center.
The prescription opioid crisis in America has led to a number of babies being born with what's known as Neonatal Abstinence Syndrome (NAS). Expectant mothers who expose their fetus to opioids of any kind face the risk of giving birth to a child with NAS. The syndrome is the result of withdrawal from the opioid pain medication. Treating infants with NAS is complicated and requires trained medical personnel which can be costly. A new report has found that the costs of NAS treatment for babies have increased dramatically, Science Daily Reports. "At our institution, costs associated with treating infants with NAS are exponentially higher than the costs associated with infants not affected," write Dr. Kay Roussos-Ross, Assistant Professor of Obstetrics and Gynecology, and colleagues of University of Florida College of Medicine, Gainesville. The researchers analyzed cost trends for infants with NAS at one university-affiliated hospital between 2008 and 2011. Over the course of the three year study, Dr. Roussos-Ross and coauthors found 160 opioid-exposed newborns:
- 40 in the first year.
- 57 in the second year.
- 63 in the third year.
- About $1.1 million in the first year.
- $1.5 million in the second year.
- $1.8 million in the third year.
As the federal government and the implementation of state prescription drug monitoring programs make it more difficult for opioid abusers to get their hands on OxyContin ® (oxycodone), many have turned to heroin as an easier, cheaper and stronger alternative. When compared to a decade ago, today it is much easier for opioid addicts to get their hands on heroin - resulting in a surge of heroin overdoses across the country. “Most people who use heroin in the U.S. today used prescription opioids first. Reducing inappropriate prescribing will prevent overdose from prescription opioids and heroin,” said CDC Director Tom Frieden, MD, MPH, in a news release. Heroin overdose deaths nearly tripled from 2010 to 2013 in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC). In California, emergency departments have seen a six-fold increase in heroin poisonings in the last decade, Reuters reports. In 2014 alone, California emergency rooms treated 1,300 young adults between the ages of 20 and 29 for heroin poisoning. "It's consistent with what we're seeing in our narcotic treatment programs - just a lot more young people," said Tom Renfree, who heads substance abuse disorder services for the County Behavioral Health Directors Association in Sacramento. "There's been a real spike." Heroin poisoning is not exclusive to overdoses; it also represents those who used a product ‘cut’ with something potentially lethal, according to the article. Across the country, there has been a rise in heroin cut with the opioid analgesic Fentanyl ®, users are often unaware just how powerful Fentanyl ® (100 times the strength of morphine) is, making dosing extremely difficult. Young adults were not the only age group affected in recent years. During the same period, adults ages 30 to 39 who were seen in emergency rooms for heroin poisoning doubled - from about 300 to about 600. Among teenagers, in 2014 there were 367 teens treated for heroin poisoning - compared with about 250 in 2005.